Sun Pharma to acquire Innovcare Lifesciences in ₹271 crore deal

Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about ₹271 crore ($28.73 million).

Source

Leave a Reply

Your email address will not be published. Required fields are marked *

six − 5 =